The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Re­silience inks man­u­fac­tur­ing pact with ARCH-backed cell ther­a­py start­up as it preps for the long haul

4 years ago
Deals

With mon­key­pox cas­es ris­ing, one Eu­ro­pean coun­try is lock­ing down a small­pox vac­cine con­tract

4 years ago
Pharma

Bavar­i­an Nordic se­cures BAR­DA con­tract for small­pox vac­cine

4 years ago
Deals
Pharma

Long-ex­pect­ed UK lay­offs im­mi­nent for No­var­tis fol­low­ing sale

4 years ago
Pharma

Amidst R&D reshuf­fle, Ver­tex ex­pands its pres­ence in Boston, aim­ing to be­come num­ber one

4 years ago
R&D

A CRL lat­er, Gilead clears clin­i­cal hold on next-gen HIV drug — af­ter find­ing a new glass vial for it

4 years ago
FDA+

Emer­gent inks $225M cash small­pox deal as Chimerix im­plodes on re­org, FDA trou­ble

4 years ago
Pharma

UK gener­ics mak­er shut­ters, elim­i­nat­ing 1,000 jobs

4 years ago
Pharma

Bris­tol My­ers Squibb strikes deal to sell NY site to South Ko­re­an con­glom­er­ate — but it's keep­ing qui­et on the de­tails

4 years ago
Deals
Pharma

Af­ter ramp­ing up its vac­cine pro­duc­tion in South Africa, As­pen yet to re­ceive a sin­gle or­der

4 years ago
Pharma

PCI fur­ther ex­pands in­to New Eng­land with fill-fin­ish up­grade in New Hamp­shire

4 years ago
Pharma

Q&A: Through ro­bot­ics, Fred Pari­et­ti and team look to fix cell ther­a­py's fu­ture

4 years ago
Pharma

Brigham and Wom­en's gets FDA warn­ing let­ter af­ter PET op­er­a­tion vi­o­la­tions

4 years ago
Pharma

Cy­ti­va's lat­est project to open in Switzer­land at the end of the month

4 years ago
Pharma

Wis­con­sin giv­ing Ar­row­head Phar­ma­ceu­ti­cals some ched­dar as their new man­u­fac­tur­ing site re­ceives sev­er­al mil­lion in state and lo­cal tax ben­e­fits

4 years ago
Pharma

Sun Phar­ma site hit with sec­ond Form 483 in 3 years

4 years ago
Pharma

Emer­gent tossed near­ly 400M Covid-19 vac­cine dos­es in Bal­ti­more de­ba­cle, House re­port says

4 years ago
Pharma
Coronavirus

Home­grown mR­NA Thai vac­cine for Covid-19 could be ready by year end — re­port

4 years ago
Pharma

Try­ing to avoid a CRL? New FDA draft guid­ance talks ben­e­fit-risks on qual­i­ty as­sess­ments

4 years ago

Ex-Sanofi CEO on board, a new $158M SPAC de­buts look­ing to shake up the Eu­ro­pean CD­MO mar­ket

4 years ago
Pharma

Con­sor­tium to au­to­mate cell ther­a­py man­u­fac­tur­ing wel­comes Ther­mo Fish­er and Charles Riv­er Labs

4 years ago
Pharma

Two No­var­tis sites stop man­u­fac­tur­ing can­cer ther­a­pies af­ter qual­i­ty is­sues

4 years ago
Pharma

FDA to cre­ate train­ing pro­gram to in­spect more mR­NA vac­cine man­u­fac­tur­ing

4 years ago
Pharma

So­ci­etal nabs sole sup­pli­er role for Ri­tal­in to Eu­rope

4 years ago
Pharma
First page Previous page 52535455565758 Next page Last page
A service from the Financial Times